CRA Skills Lacking in Critical Areas
A global CRO’s data gathered using an objective monitoring simulation administered by CRA Assessments, LLC reveals that CRAs are consistently underperforming regardless of the level of experience or training.
Gene Therapy in Rare Diseases: Home and Dosing Site Considerations
With the rise in gene therapies entering clinical trials, it is important to address the operational challenges associated with these types of trials.
Clinical Trial mHealth Update: an EU Perspective
The biopharmaceutical industry continues to explore how mHealth can change clinical trials, as the discussion continued at Hanson Wade’s mHealth for Clinical Trials EU Summit in London.
Big data study by Elsevier probes how well animal studies predict human safety
Elligo Health Research Launches Research Ready Program
Research Ready™ Program Expands and Diversifies Clinical Trial Patient Populations
Elsevier Study Probes How Animal Studies Predict Human Safety
NovaQuest Private Equity Acquires Majority Interest in Clinical Ink
Clinical Ink to Accelerate Innovaion and Growth with Major Investment by Novaquest Private Equity
Latest Business and People News
Updated employee announcements, business news, awards, and recognition in the industry today.
What's the EMA Worth?
On Europe Day, the agency itself is right now keener than ever to assess its worth and the value of its services to Europe and to Europeans.
CRF Health’s eCOA Solution Selected for Large-Scale Insomnia Study by Innovative European Pharmaceutical Company
CRF Health’s eCOA Solution Selected for Large-Scale Insomnia Study
How Informed are your Participants? RTI International Champions Patient-Centered Consent for Clinical Trials
How Informed are your Participants?
OmniComm Systems Introduces AutoEncoder
OmniComm Systems Introduces AutoEncoder, a Coding Solution for Clinical Trials
Blockchain Concepts Emerge in Clinical Trials
In this interview, Munther Baara, Head of New Clinical Paradigms at Pfizer, will discuss his perspectives on how blockchain may impact clinical trials.
Clinical Trials Don't Have to Cost Too Much or Take Too Long
A discussion of the cost and time put into clinical trials.
Monoclonal Antibodies: Clinical Pharmacology Knowledge in Support of FIH and Early Development
There are several pharmacokinetic factors and peculiarities that should be considered carefully when designing and running first-in-human (FIH) studies for monoclonal antibodies.
MMS Partners with University of Findlay to Provide Medical Writing and Clinical Trial Disclosure Courses
MMS Partners with University of Findlay
Oncology Therapy-Focused RACT Emerges
Newest revelations suggest Risk Assessment Categorization Tools are now becoming therapeutic area-specific, as an oncology-based risk library is now surfacing.
BMS and Biomarker Research: An Interview with Saurabh Saha
BMS executive shares his perspectives on the current biomarker landscape, the role of translational medicine in accelerating this area of study, and how BMS is working to advance biomarker research across their R&D portfolio.
"Right-to-Try" Scope Expanding to Europe?
Peter O’Donnell explores potential parallels of the U.S. “right-to-try” debate in Europe.
Maximizing Immuno-Oncology Clinical Trial Success
Examining the unique standards and related challenges when assessing the safety and efficacy of cancer immunotherapy candidates.
Applied Clinical Trials, May 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials May 2018 issue in an interactive PDF format.
Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery
Syneos Health Launches Catalyst Ophthalmology Site Network
Belgium Draws a Clear Line on "Right-to-Try"–and Backs Research Independence
An additional light has been shone on the "right-to-try" debate in Europe by a strongly-worded statement from Belgium's feisty health minister, Maggie De Block.
